12-month mortality and loss-to-program in antiretroviral-treated children: The IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008

Ekouevi, Didier K.; Azondekon, Alain; Dicko, Fatoumata; Malateste, Karen; Touré, Pety; Eboua, François T.; Kouadio, Kouakou; Renner, Lorna; Peterson, Kevin; Dabis, François; Signaté Sy, Haby; Leroy, Valeriane
January 2011
BMC Public Health;2011, Vol. 11 Issue 1, p519
Academic Journal
Background: The IeDEA West Africa Pediatric Working Group (pWADA) was established in January 2007 to study the care and treatment of HIV-infected children in this region. We describe here the characteristics at antiretroviral treatment (ART) initiation and study the 12-month mortality and loss-to-program of HIV-infected children followed in ART programs in West Africa. Methods: Standardized data from HIV-infected children followed-up in ART programs were included. Nine clinical centers from six countries contributed to the dataset (Benin, Côte d'Ivoire, Gambia, Ghana, Mali and Senegal). Inclusion criteria were the followings: age 0-15 years and initiated triple antiretroviral drug regimens. Baseline time was the date of ART initiation. WHO criteria was used to define severe immunosuppression based on CD4 count by age or CD4 percent < 15%. We estimated the 12-month Kaplan-Meier probabilities of mortality and loss-toprogram (death or loss to follow-up > 6 months) after ART initiation and factors associated with these two outcomes. Results: Between June 2000 and December 2007, 2170 children were included. Characteristics at ART initiation were the following: median age of 5 years (Interquartile range (IQR: 2-9) and median CD4 percentage of 13% (IQR: 7-19). The most frequent drug regimen consisted of two nucleoside reverse transcriptase inhibitors and one nonnucleoside reverse transcriptase inhibitors (62%). During the first 12 months, 169 (7.8%) children died and 461 (21.2%) were lost-to-program. Overall, in HIV-infected children on ART, the 12-month probability of death was 8.3% (95% Confidence Interval (CI): 7.2-9.6%), and of loss-to-program was 23.1% (95% CI: 21.3-25.0%). Both mortality and loss-to program were associated with advanced clinical stage, CD4 percentage < 15% at ART initiation and year (> 2005) of ART initiation. Conclusion: Innovative and sustainable approaches are needed to better document causes of death and increase retention in HIV pediatric clinics in West Africa.


Related Articles

  • Essential medicines for children. Hoppu, Kalle; Ranganathan, Shalini Sri // Archives of Disease in Childhood;Feb2015, Vol. 100 Issue Supp1, ps38 

    Millions of children die every year before they reach the age of 5 years, of conditions largely treatable with existing medicines. The WHO Model List of Essential Medicines was launched in 1977 to make the most necessary drugs available to populations whose basic health needs could not be met by...

  • Main infections in the children under 5 years old in developing countries: reports and perspectives. Courpotin, Christian // Retrovirology;2008 Supplement 1, Vol. 5, Special section p1 

    Spectacular progress in reducing under 5 mortality achieved in the last few decades is projected to continue. There were about 11 million such deaths in 1997 compared to 21 million in 1955. The under-5 mortality rates per 1000 live births was 210 in 1955 and is projected to be 37 in 2025. Today...

  • Despite access to ART, mortality still reported among children in Uganda.  // Infectious Diseases in Children;Aug2012, Vol. 25 Issue 8, p12 

    The article reports on the 19th International AIDS Conference where a study presented by Ruth Atukunda of the University of Maryland School of Medicine Institute of Human Virology-Uganda Program and colleagues advocated for careful documentation of CD4 counts and early initiation of...

  • Community engagement and mobilisation of local resources to support integrated Community Case Management of childhood illnesses in Niger State, Nigeria. Alegbeleye, Ayodele; Dada, John; Oresanya, Olusola; Jiya, Jonathan; Counihan, Helen; Gimba, Patrick; Ozor, Lynda; Maxwell, Kolawole // Journal of Global Health;Jun2019, Vol. 9 Issue 1, p1 

    Background: Despite strong evidence of integrated community case management (iCCM) of childhood illnesses being a proven intervention for reducing childhood morbidity and mortality, sustainability remains a challenge in most settings. Community ownership and contribution are...

  • Risk Factors for First-line Antiretroviral Treatment Failure in HIV-1 Infected Children Attending Jos University Teaching Hospital, Jos, North Central Nigeria. Ebonyi, Augustine O.; Oguche, Stephen; Ejeliogu, Emeka U.; Okpe, Sylvanus E.; Agbaji, Oche O.; Sagay, Solomon A.; Okonkwo, Prosper; Idoko, John A.; Kanki, Phyllis // British Journal of Medicine & Medical Research;5/21/2014, Vol. 4 Issue 15, p2983 

    Aim: To determine risk factors for first-line antiretroviral treatment failure in HIV-1 infected children attending Jos University Teaching Hospital, Jos. Study Design: Retrospective cohort study. Place and Duration of Study: Paediatric HIV clinic at the Jos University Teaching Hospital, Jos,...

  • Liver Failure in a Child Receiving Highly Active Antiretroviral Therapy and Voriconazole. Scherpbier, Henriette J.; Hilhorst, Michaela I.; Kuijpers, Taco W. // Clinical Infectious Diseases;9/15/2003, Vol. 37 Issue 6, p828 

    Presents a case of liver failure in a child receiving highly active antiretroviral therapy and voriconazole. Increase of liver enzyme levels one day after the start of voriconazole therapy; Metabolic impact of the protease inhibitors as a substrate of the cytochrome p450 isoenzymes; Exhibition...

  • Estimating the number of vertically HIV-infected children eligible for antiretroviral treatment in resource-limited settings. Kirsty Little; Marie-Louise Newell; Chewe Luo; Ngashi Ngongo; Mario Cortina Borja; Peter McDermott // International Journal of Epidemiology;Jun2007, Vol. 36 Issue 3, p679 

    Background With the gradual roll-out of antiretroviral therapy (ART) to delay progression of HIV disease in children in programmes across sub-Saharan Africa and resource-limited settings elsewhere, reliable information on the number of vertically infected children eligible for such treatment is...

  • Childhood deaths from acute appendicitis in England and Wales 1963-97: observational population based study. Pledger, Gordon; Stringer, Mark D // BMJ: British Medical Journal (International Edition);8/25/2001, Vol. 323 Issue 7310, p430 

    Reports on an audit of children dying from acute appendicitis in England and Wales in 1993-1997. Comparison with earlier audits in the 1960's and 1980's; Methods and results; Suggested reasons for a significant reduction in the number of deaths attributable to acute appendicitis, including...

  • Community Case Management of Fever Due to Malaria and Pneumonia in Children Under Five in Zambia: A Cluster Randomized Controlled Trial. Kojo Yeboah-Antwi; Pilingana, Portipher; Macleod, William B.; Semrau, Katherine; Siazeele, Kazungu; Kalesha, Penelope; Hamainza, Busiku; Seidenberg, Phil; Mazimba, Arthur; Sabin, Lora; Kamholz, Karen; Thea, Donald M.; Hamer, Davidson H. // PLoS Medicine;Sep2010, Vol. 7 Issue 9, p1 

    Background: Pneumonia and malaria, two of the leading causes of morbidity and mortality among children under five in Zambia, often have overlapping clinical manifestations. Zambia is piloting the use of artemether-lumefantrine (AL) by community health workers (CHWs) to treat uncomplicated...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics